S. 1040 · 119th Congress

Drug Competition Enhancement Act

Stage: Reported from committee
Sponsor: John Cornyn
Introduced: 2025-03-13
Latest action: 2025-04-10 · Committee on the Judiciary. Reported by Senator Grassley with an amendment. Without written report.

Subjects

Health care costs and insurance

Health

Civil actions and liability

Inflation and prices

Consumer affairs

Intellectual property

Prescription drugs

Competition and antitrust

Drug safety, medical device, and laboratory regulation

Manufacturing

Administrative remedies

Judicial review and appeals

Federal Trade Commission (FTC)